Deloitte becomes a CORDIA premier sponsor


Deloitte has become a Premier Sponsor for CORDIA - EuropaBio Convention, which takes place the 2-4 December in Vienna, Austria.

Deloitte's decision to be a major sponsor of CORDIA has been driven by the convention's successful build-up amongst the international biotech community, putting it on course to represent a major global event for the industry.

Mr Stuart Henderson, partner at Deloitte, who will chair the closing plenary of the conference on the 4th December, commented: 'This year has been an exciting one in the European biotech sector. Several high profile product successes, encouraging clinical trial results and a long overdue kick-start to consolidation have led to a feeling of optimism within the sector. '

' CORDIA - EuropaBio convention 2003 has attracted major interest within the industry around the world. In addition to the US and Australia, ever more countries from Europe, Asia, and the Middle East are joining our event', said Mr. Hugo Schepens, Secretary General for EuropaBio and Chairman of CORDIA's Steering Group.

He added: 'CORDIA is on track to become the major international forum needed by the biotechnology industry in Europe.'

CORDIA'S exhibition will combine national pavilions with independent stands featuring leading biotech and pharmaceutical companies, and key industry advisors including VCs, lawyers and consultants. The growing list of countries that will be represented so far include: Austria, Australia, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, India, Ireland, Israel, Italy, Japan, The Netherlands, Norway, Portugal, Slovakia, Sweden, Switzerland, the United Kingdom, and the United States.

Other high profile companies that have taken the opportunity to sponsor CORDIA are listed below, and more sponsorship opportunities are still available from CORDIA's organisers. CORDIA will take place from 2-4 December 2003 in Vienna, Austria. Full details of the conference, exhibition, partnering forum, as well as sponsorship opportunities can be found at

About CORDIA The first convention of its kind in Europe, CORDIA - EuropaBio Convention 2003 takes place from 2-4 December 2003 at the Messe Wien, Vienna, Austria.

CORDIA - EuropaBio Convention 2003, is the first Pan-European biotechnology Conference specifically tailored for the sector. Through partnering, networking and exhibitions, it will explore and influence the issues impacting on bioscience growth across Europe including technology transfer, product development and commercialisation, regulation, capital and resourcing.

The Convention will be an opportunity to showcase science and technology innovations, as well as providing the European industry with an unprecedented critical mass for learning, networking and doing business.

CORDIA - EuropaBio Convention 2003 will provide an environment for small, medium and large life science and biotech companies in the sector, along with investors, regulators, policy-makers, contract service providers and advisors as well as entrepreneurial scientists and clinicians to meet up and explore the potential of their business together.

CORDIA 2003 is being organised by three partners; EuropaBio, the European Association for Bioindustries, Technomark the specialist life science consulting and investment group and Reed Exhibitions, the world's largest event organiser. EuropaBio represents about 35 member companies operating worldwide and 22 national biotechnology associations with over 1200 SME members. Industry representatives, financiers, regulators, patients, NGO's, and politicians have all been involved in preparations to date to ensure relevant, high-level conference topics and seminars.

  • List of confirmed CORDIA's sponsors: Avecia Biotechnology Baxter AG Bio Fund Management Bird & Bird Bristol Myers Squibb Pharmaceutical Ltd BTG plc Chubb Insurance of Europe SA. Deloitte Genencor International B.V. Genzyme Belgium NV/SA Hesperion Ltd IBM - Life Sciences EMEA Novozymes A/S Pall Corporation Serono International SA Taylor Wessing

    About Deloitte

    Deloitte Touche Tohmatsu is an organization of member firms devoted to excellence in providing professional services and advice. We are focused on client service through a global strategy executed locally in nearly 150 countries. With access to the deep intellectual capital of 120,000 people worldwide, our member firms (including their affiliates) deliver services in four professional areas: audit, tax, consulting and financial advisory services.

    Our member firms serve over one-half of the world's largest companies, as well as large national enterprises, public institutions, and successful, fast-growing global growth companies.

    Deloitte Touche Tohmatsu is a Swiss Verein (association), and, as such, neither Deloitte Touche Tohmatsu nor any of its member firms has any liability for each other's acts or omissions. Each of the member firms is a separate and independent legal entity operating under the names 'Deloitte,' 'Deloitte & Touche,' 'Deloitte Touche Tohmatsu,' or other related names. The services described herein are provided by the member firms and not by the Deloitte Touche Tohmatsu Verein. For regulatory and other reasons certain member firms do not provide services in all four professional areas listed above.



    For all countries except Germany, Austria and Switzerland: Richard Anderson at the CORDIA Press Office, De Facto Communications plc

    +44 (0) 207 496 3310

    For Germany, Austria and Switzerland: Till C. Jelitto at the CORDIA Press Office, PR & D

    +43 1 505 70 44

    The Deloitte Cambridge office comprises 8 Partners and over 250 staff who deliver a full range of professional services to the East Anglian region. As well as focussing on the life sciences and technology sectors for which the region has become so renowned, the office has long standing specialisms in other sectors including the professions, consumer business, food and agribusiness.

    Deloitte LLP